Page 1 of Clinical Trials for ovarian epithelial cancer, 838 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Exhaled Breath Biomarkers in Finding Ovarian Epithelial Cancer in Patients With Newly Diagnosed Ovarian Epithelial Cancer, Polycystic Ovarian Syndrome, or Endometriosis and in Healthy Participants
Last Updated: July 1, 2009
Condition(s): Ovarian Cancer
2
Active, not recruiting
Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
Last Updated: July 23, 2008
Condition(s): Ovarian Cancer
3
Active, not recruiting
Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer
Last Updated: April 23, 2011
Condition(s): Ovarian Cancer; Primary Peritoneal Cavity Cancer
4
Active, not recruiting
Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer
Last Updated: August 17, 2010
Condition(s): Fallopian Tube Cancer; Ovarian Cancer
5
Recruiting
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
Last Updated: May 1, 2012
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
6
Completed
Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Last Updated: April 23, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
7
Recruiting
Comparing Three Combination Chemotherapy Regimens in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Last Updated: March 9, 2012
Condition(s): Fallopian Tube Cancer; Metastatic Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
8
Suspended
FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer
Last Updated: January 20, 2010
Condition(s): Ovarian Cancer
9
Completed
Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer
Last Updated: March 16, 2010
Condition(s): Ovarian Cancer
10
Completed
Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer
Last Updated: November 7, 2010
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
11
Active, not recruiting
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
Last Updated: July 8, 2011
Condition(s): Ovarian Cancer
12
Completed
Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
Last Updated: February 6, 2009
Condition(s): Ovarian Cancer
13
Completed
Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Last Updated: July 7, 2011
Condition(s): Ovarian Cancer; Primary Peritoneal Cavity Cancer
14
Active, not recruiting
Comparison of Combination Chemotherapy Regimens in Treating Newly Diagnosed Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Last Updated: April 11, 2012
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
15
Completed
TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Last Updated: April 23, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
16
Not yet recruiting
Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182
Last Updated: February 23, 2010
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
17
Recruiting
Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)
Last Updated: January 25, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
18
Active, not recruiting
Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy
Last Updated: June 21, 2011
Condition(s): Ovarian Cancer
19
Completed
S0009 Combination Chemotherapy and Surgery in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Last Updated: July 19, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
20
Suspended
Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer
Last Updated: July 20, 2009
Condition(s): Depression; Fatigue; Ovarian Cancer; Psychosocial Effects of Cancer and Its Treatment; Sleep Disorders

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=ovarian+epithelial+cancer

Page 1 of Clinical Trials for ovarian epithelial cancer, 838 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About